GenomeWeb
Julia Karow
April 3, 2017
Spera Genomics is offering patients in Canada a preventive whole-genome sequencing service with annually updated clinical reports, all in the context of a long-term research study.
The company, a division of Spera Medical — a small cardiology clinic near Montreal that was founded by cardiologist and current CEO Deepak (Bobby) Jain — received approval for the whole-genome sequencing study of healthy individuals from a Canadian ethical review board late last year and is now ready to sign up its first clients. Participants in the study and service, which Jain said is the first of its kind in Canada, need to pay C$4,000 upfront and a monthly subscription fee of C$180.